Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 3/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.34 |
| ▸ | ACACB | O00763 | 3/20 | 0.34 |
| ▸ | ACACA | Q13085 | 3/20 | 0.34 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | WDR5 | P61964 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | RARA | P10276 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25445532 | 0.94 | MCL1 (0.38) | MCL1PDK2ACACBACACAMAP4K4 | |
| SCHEMBL25444650 | 0.94 | MCL1 (0.38) | MCL1PDK2ACACBACACAMAP4K4 | |
| SCHEMBL25445453 | 0.93 | MAP4K4 (0.38) | MCL1PDK2ACACBACACAMAP4K4 | |
| SCHEMBL25445624 | 0.92 | PDK2 (0.32) | MCL1PDK2ACACBACACA | |
| SCHEMBL25445903 | 0.91 | PDK2 (0.38) | MCL1PDK2ACACBACACAMAP4K4 | |
| SCHEMBL25445542 | 0.86 | MCL1 (0.33) | MCL1PDK2MAP4K4 | |
| SCHEMBL25445892 | 0.85 | PDK2 (0.44) | MCL1PDK2MAP4K4 | |
| SCHEMBL25445553 | 0.84 | PDK2 (0.35) | MCL1PDK2MAP4K4MAPTALDH1A1 | |
| SCHEMBL25445613 | 0.84 | MCL1 (0.31) | MCL1 | |
| SCHEMBL25444742 | 0.82 | PDK2 (0.36) | MCL1PDK2MAP4K4TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143779-A1 | ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143779-A1 | ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF | LEF1, CCNT1, CCNT2 | MCL1 1322/4885PDK2 3407/4885ACACB 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.